MARC

LEADER 00000ngm a2200000 a 4500
001 HST4337
003 UkLoHST
006 m c
007 cr|cna|||a||||
007 vz|czazum
008 161024s2016 enk|||||||||||s|||v|eng d
028 5 0 |a 4337  |b Henry Stewart Talks 
035 |a (UkLoHST)3360 
040 |a UkLoHST  |b eng  |c UkLoHST 
100 1 |a Ivanova, Anastasia,  |u (The University of North Carolina at Chapel Hill, USA)  |4 spk 
245 1 0 |a Adaptive designs for phase I trials  |h [electronic resource] :  |b part 2 of 2 /  |c Anastasia Ivanova. 
246 3 |a Adaptive designs for phase I trials. Part 2. 
260 |a London :  |b Henry Stewart Talks,  |c 2016. 
300 |a 1 online resource (1 streaming video file (22 min.) :  |b color, sound). 
490 1 |a Adaptive clinical trial design,  |x 2056-452X 
490 1 |a The risk of bias in randomized clinical trials,  |x 2056-452X 
500 |a Animated audio-visual presentation with synchronized narration. 
500 |a Title from title frames. 
505 0 |a Contents: Continual Reassessment Method (CRM) -- Dose-finding designs for trials with delayed outcome -- Designs for dose-finding trials with multiple agents & ordered subpopulations. 
506 |a Access restricted to subscribers. 
538 |a Mode of access: World Wide Web. 
650 0 |a Adaptive sampling (Statistics). 
650 0 |a Clinical trials  |x Statistical methods. 
650 0 |a Research  |x Design. 
650 2 |a Clinical Trials, Phase I as Topic  |x methods. 
650 2 |a Dose-Response Relationship, Drug. 
650 2 |a Randomized Controlled Trials as Topic  |x statistics & numerical data. 
650 2 |a Research Design  |x statistics & numerical data. 
830 0 |a Henry Stewart talks.  |p Biomedical & life sciences collection.  |p Adaptive clinical trial design. 
830 0 |a Henry Stewart talks.  |p Biomedical & life sciences collection.  |p Risk of bias in randomized clinical trials. 
856 4 0 |u https://hstalks.com/bs/3360/ 
856 4 2 |u https://hstalks.com/bs/p/1005/  |3 Series (Risk of bias in randomized clinical trials) 
856 4 2 |u https://hstalks.com/bs/p/1021/  |3 Series (Adaptive clinical trial design) 
999 |c 200805  |d 200805